Kaila Krum analyst

Currently out of the existing stock ratings of Kaila Krum, 57 are a BUY (90.48%), 6 are a HOLD (9.52%).

Kaila Krum

Work Performance Price Targets & Ratings Chart

Analyst Kaila Krum, currently employed carries an average stock price target met ratio of 61.9% that have a potential upside of 19.87% achieved within 139 days.

Kaila Krumā€™s has documented 122 price targets and ratings displayed on 15 stocks. The coverage was on Healthcare, Industrials sectors.

Most recent stock forecast was given on KIDS, Orthopediatrics Corp at 25-Jan-2024.

Wall Street Analyst Kaila Krum

Analyst best performing recommendations are on VCEL (VERICEL CORP ORD).
The best stock recommendation documented was for IRTC (IRHYTHM TECHNOLOGIES) at 12/2/2020. The price target of $240 was fulfilled within 21 days with a profit of $47.79 (24.86%) receiving and performance score of 11.84.

Average potential price target upside

BSX Boston Scientific Corp IART Integra LifeSciences Holdings IRT Independence Realty Trust IRTC iRhythm Technologies KIDS Orthopediatrics Corp SPNE SeaSpine Holdings Corp SYK Stryker VCEL Vericel Corp Ord ZBH Zimmer Biomet Holdings MDT Medtronic PLC NVRO Nevro Corp AZYO Aziyo BiologicsĀ  AXNX Axonics Modulation Technologies NUVA NuVasive AIR AAR Corp

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

90

$12.44 (16.04%)

66

10 days ago

8/9 (88.89%)

$11.86 (15.18%)

175

Buy

86

$8.44 (10.88%)

77

10 days ago

16/17 (94.12%)

$7.86 (10.06%)

459

Buy

84

$6.44 (8.30%)

70

11 days ago

13/14 (92.86%)

$5.98 (7.66%)

367

Buy

81

$3.44 (4.44%)

72

24 days ago

9/10 (90%)

$4.45 (5.81%)

98

Buy

82

$4.44 (5.72%)

82

1 months 8 days ago

20/22 (90.91%)

$5.69 (7.46%)

319

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Kaila Krum?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?